As part of France 2030's health component "Plan innovation santé 2030", the Délégation ministérielle au Numérique en santé (DNS) has been commissioned during the 2nd half of 2022 to conduct a recensement des besoins des acteurs de l'écosystème de la recherche clinique concernant l'inclusion des volontaires dans les essais cliniques.

On the basis of the state of play presented in this report, DNS has designed several costed scenarios leading to thelaunch of experimentation around a minimum viable product (MVP) for a national clinical trials base, in conjunction with the French Health Ministry's Directorate General for Health (DGS) and Digital Affairs Directorate (DNUM).

Work on an MVP for a national clinical trials database linked to the RIPH 2G IS was launched on January 18, 2023. Santé.fr will be the first interface with the national database.